Lilly and Regeneron's monoclonal antibodies use exactly that as primary endpoint. Unfortunately, most of them are e.v., with exception of one formulation by Reg

Lilly and Regeneron's monoclonal antibodies use exactly that as primary endpoint. Unfortunately, most of them are e.v., with exception of one formulation by Regeneron, which is subcutaneous.